Medical Weight Loss for Kenai, Alaska Residents
Kenai, Alaska residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Kenai through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Kenai Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Kenai, Alaska residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Kenai residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Kenai address.
Patients across Kenai and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Alaska. We care for patients throughout Kenai and the greater Kenai Peninsula area. Whether you are starting your first GLP-1 program or switching from a brand medication, your Kenai treatment plan is built around your health history and goals.
Telehealth removes the distance between Kenai and specialized care: your consultation happens wherever you are in Alaska. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Kenai patients.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Kenai
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Kenai
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Kenai address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Kenai
Does New Hope Weight Loss treat patients in Kenai?
Yes. Although the clinic is in Costa Mesa, California, we treat Kenai, Alaska residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Kenai?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Kenai address in cold-pack packaging.
What do Kenai patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Kenai do you serve?
We serve patients from across Kenai by telehealth, including Kenai and the greater Kenai Peninsula area.
What makes this different from a local Kenai medspa or clinic?
A named, licensed physician, Dr. Anjmun Sharma, supervises every case. Contraindications are screened at intake, the 503(a) compounding pharmacy is identified, and pricing is flat and stated up front. Kenai patients get a real physician-led medical practice by telehealth, not a quick membership sign-up.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Kenai, Alaska by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.